DUBLIN, Mar 02, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Chronic Obstructive Pulmonary Disease Market Analysis 2016 - Forecast to 2022" report to their offering.
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.
This report analyzes the global markets for "Chronic Obstructive Pulmonary Disease". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America).
This report provides:
- Market Sizing estimations and forecasts for a minimum of 6 years of all the given segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Strategic recommendations for the new entrants
Companies Profiled:
- GlaxoSmithKline
- Boehringer Ingelheim
- Nycomed
- Novartis
- AstraZeneca
- Rottapharm | Madaus
- Theravance
- Nucala
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Market Analysis
4 Porters Five Force Analysis
5 Chronic Obstructive Pulmonary Disease Market by Product
6 Geographical Segmentation
7 Vendor Landscaping
8 Company Profiles
9 Appendix
For more information about this report visit http://www.researchandmarkets.com/research/lbh5bg/global_chronic
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article